Cytokine-based therapies for HIV infection

被引：6

作者：

Allende, MC ^{[1
]}

Lane, HC ^{[1
]}

机构：

[1] NIAID, Clin & Mol Retrovirol Sect, NIH, Bethesda, MD 20892 USA

来源：

AIDS | 2001年 / 15卷

关键词：

HIV; immune-based therapies; cytokines; interleukin-2; vaccines;

D O I：

10.1097/00002030-200100005-00022

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

收藏

页码：S183 / S191

页数：9

相关论文

共 61 条

[1]

ABRAMS DI, 2000, 40 INT C ANT AG CHEM

[2]

Aladdin H, 2000, SCAND J IMMUNOL, V51, P520

[3] Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression [J].

Amiel, C ;

Darcissac, E ;

Truong, MJ ;

Dewulf, J ;

Loyens, M ;

Mouton, Y ;

Capron, N ;

Bahr, GM .

JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (01) :83-91

[4] A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects [J].

Angel, JB ;

Jacobson, MA ;

Skolnik, PR ;

Giordano, M ;

Shapiro, L ;

LeBeaut, A ;

Greaves, W ;

Fuchs, AC .

AIDS, 2000, 14 (16) :2503-2508

[5] Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression [J].

Angel, JB ;

High, K ;

Rhame, F ;

Brand, D ;

Whitmore, JB ;

Agosti, JM ;

Gilbert, MJ ;

Deresinski, S .

AIDS, 2000, 14 (04) :387-395

[6] Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with ≤250/μL CD4 T cells and undetectable plasma virus load [J].

Arnó, A ;

Ruiz, L ;

Juan, M ;

Jou, A ;

Balagué, M ;

Zayat, MK ;

Marfil, S ;

Martínez-Picado, J ;

Martínez, MA ;

Romeu, J ;

Pujol-Borrell, R ;

Lane, C ;

Clotet, B .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (01) :56-60

[7] Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: A randomized, controlled, multicenter study [J].

Carr, A ;

Emery, S ;

Lloyd, A ;

Hoy, J ;

Garsia, R ;

French, M ;

Stewart, G ;

Fyfe, G ;

Cooper, DA .

JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (04) :992-999

[8] Spontaneous programmed cell death of peripheral blood mononuclear cells from HIV-infected persons is decreased with interleukin-15 [J].

Chang, KH ;

Kim, JM ;

Kim, HY ;

Song, YG ;

Choi, YH ;

Park, YS ;

Cho, JH ;

Hong, SK .

YONSEI MEDICAL JOURNAL, 2000, 41 (01) :112-118

[9] AIDS - Re-emergence of HIV after stopping therapy [J].

Chun, TW ;

Davey, RT ;

Engel, D ;

Lane, HC ;

Fauci, AS .

NATURE, 1999, 401 (6756) :874-875

[10] HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression [J].

Davey, RT ;

Bhat, N ;

Yoder, C ;

Chun, TW ;

Metcalf, JA ;

Dewar, R ;

Natarajan, V ;

Lempicki, RA ;

Adelsberger, JW ;

Millers, KD ;

Kovacs, JA ;

Polis, MA ;

Walker, RE ;

Falloon, L ;

Masur, H ;

Gee, D ;

Baseler, M ;

Dimitrov, DS ;

Fauci, AS ;

Lane, HC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15109-15114

← 1 2 3 4 5 6 7 →